Silvio Danese (S Danese)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 201

Top Venues

Alimentary pharmacology & therapeutics

Journal of Crohn's & colitis

Journal of clinical medicine

Nature reviews. Gastroenterology & hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Lusetti, Ferdinando D'Amico, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Gionata Fiorino, Tommaso Lorenzo Parigi, Simona Radice, Laurent Peyrin-Biroulet, Silvio Danese
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease. Immunotherapy 16 (9) (2024)
Léa Sequier, Bénédicte Caron, Damien Loeuille, Sailish Honap, Vipul Jairath, Patrick Netter, Silvio Danese, Jean Sibilia, Laurent Peyrin Biroulet
Systematic review: Methotrexate-A poorly understood and underused medication in inflammatory bowel disease. Alimentary pharmacology & therapeutics 60 (6) (2024)
Fernando Magro, Samuel Fernandes, Marta Patita, Bruno Arroja, Paula Lago, Isadora Rosa, Helena Tavares de Sousa, Paula Ministro, Irina Mocanu, Ana Vieira, Joana Castela, Joana Moleiro, Fernando Magro, Eugénia Cancela, Paula Sousa, Francisco Portela, Luís Correia, Paula Moreira, Sandra Dias, Joana Afonso, Silvio Danese, Laurent Peyrin-Biroulet, Katarina M Vucicevic, Mafalda Santiago
The influence of subclinical active inflammation on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patients. Journal of Crohn's & colitis (2024)
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, Julian Panés, Stefan Schreiber, Walter Reinisch, Brian G Feagan, Silvio Danese, Andres J Yarur, Geert R D'Haens, Martina Goetsch, Karolina Wosik, Michael Keating, Krisztina Lazin, Joseph Wu, Irene Modesto, Aoibhinn McDonnell, Lauren Bartolome, Séverine Vermeire
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme. Journal of Crohn's & colitis (2024)
Mariangela Allocca, Gaia Catalano, Edoardo V Savarino, Maria Chaparro, Asaf Levartovsky, George Michalopoulos, Nikos Viazis, Fotis S Fousekis, Andreas Psistakis, Daniele Noviello, Catarina Neto do Nascimento, Benedicte Caron, Vassiliki Kitsou, Giorgos Bamias, María José García, Eirini Zacharopoulou, Kalliopi Foteinogiannopoulou, Ferdinando D'Amico, Ioannis Koutroubakis, Pierre Ellul, Maria Tzouvala, Laurent Peyrin Biroulet, Joanna Torres, Flavio Caprioli, Konstantinos Karmiris, Angeliki Theodoropoulou, Konstantinos H Katsanos, Dimitrios K Christodoulou, Gerassimos J Mantzaris, Uri Kopylov, Francisco Javier García-Alonso, Silvio Danese, Fernando Magro, Fornari Carla, Gionata Fiorino
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study. United European gastroenterology journal 12 (5) (2024)
Bénédicte Caron, Alexandre Habert, Olivier Bonsack, Houda Camara, Elodie Jeanbert, Tommaso Lorenzo Parigi, Patrick Netter, Silvio Danese, Laurent Peyrin Biroulet
Difficult-to-treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment. United European gastroenterology journal 12 (5) (2024)
Léa Sequier, Bénédicte Caron, Damien Loeuille, Sailish Honap, Vipul Jairath, Patrick Netter, Silvio Danese, Jean Sibilia, Laurent Peyrin Biroulet
Systematic review: Methotrexate-A poorly understood and underused medication in inflammatory bowel disease. Alimentary pharmacology & therapeutics (2024)
Francesca Lusetti, Ferdinando D'Amico, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Gionata Fiorino, Tommaso Lorenzo Parigi, Simona Radice, Laurent Peyrin-Biroulet, Silvio Danese
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease. Immunotherapy 16 (9) (2024)
Sudheer Kumar Vuyyuru, Virginia Solitano, Siddharth Singh, Jurij Hanžel, John K Macdonald, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath
Scoring Indices for Perianal Fistulising Crohn's Disease: A Systematic Review. Journal of Crohn's & colitis 18 (6) (2024)
Subrata Ghosh, Brian G Feagan, Elyssa Ott, Christopher Gasink, Bridget Godwin, Colleen Marano, Ye Miao, Tony Ma, Edward V Loftus, William J Sandborn, Silvio Danese, Maria T Abreu, Bruce E Sands
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis. Journal of Crohn's & colitis 18 (7) (2024)
Jurij Hanžel, Christopher Ma, Laurent Peyrin-Biroulet, Silvio Danese, Bruce E Sands, Vipul Jairath
Differences Between the 2016 and 2022 Food and Drug Administration Guidance-Implications for Design and Interpretation of Clinical Trials in Ulcerative Colitis. Crohn's & colitis 360 6 (2) (2024)
Mariangela Allocca, Gaia Catalano, Edoardo V Savarino, Maria Chaparro, Asaf Levartovsky, George Michalopoulos, Nikos Viazis, Fotis S Fousekis, Andreas Psistakis, Daniele Noviello, Catarina Neto do Nascimento, Benedicte Caron, Vassiliki Kitsou, Giorgos Bamias, María José García, Eirini Zacharopoulou, Kalliopi Foteinogiannopoulou, Ferdinando D'Amico, Ioannis Koutroubakis, Pierre Ellul, Maria Tzouvala, Laurent Peyrin Biroulet, Joanna Torres, Flavio Caprioli, Konstantinos Karmiris, Angeliki Theodoropoulou, Konstantinos H Katsanos, Dimitrios K Christodoulou, Gerassimos J Mantzaris, Uri Kopylov, Francisco Javier García-Alonso, Silvio Danese, Fernando Magro, Fornari Carla, Gionata Fiorino
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study. United European gastroenterology journal (2024)
Bénédicte Caron, Alexandre Habert, Olivier Bonsack, Houda Camara, Elodie Jeanbert, Tommaso Lorenzo Parigi, Patrick Netter, Silvio Danese, Laurent Peyrin Biroulet
Difficult-to-treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment. United European gastroenterology journal (2024)
Brian G Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Séverine Vermeire, Silvio Danese, Edward V Loftus, Ian L P Beales, Stefan Schreiber, Hyo Jong Kim, Margaux Faes, Angela de Haas, Tomasz Masior, Christine Rudolph, Laurent Peyrin Biroulet
Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study. Alimentary pharmacology & therapeutics (2024)
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, Julian Panes, Stefan Schreiber, Walter Reinisch, Brian G Feagan, Silvio Danese, Andres J Yarur, Geert R A M D'Haens, Martina Goetsch, Karolina Wosik, Michael Keating, Krisztina Lazin, Joseph Wu, Irene Modesto, Aoibhinn McDonnell, Lauren Bartolome, Severine Vermeire
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme. Journal of Crohn's & colitis 18 (8) (2024)
Francesca Lusetti, Ferdinando D'Amico, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Gionata Fiorino, Tommaso Lorenzo Parigi, Simona Radice, Laurent Peyrin-Biroulet, Silvio Danese
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease. Immunotherapy 16 (9) (2024)
Francesca Lusetti, Ferdinando D'Amico, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Gionata Fiorino, Tommaso Lorenzo Parigi, Simona Radice, Laurent Peyrin-Biroulet, Silvio Danese
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease. Immunotherapy 16 (9) (2024)
Silvio Danese, Gionata Fiorino, Eric Vicaut, Kristine Paridaens, Asiya Ugur, Brian Clark, Tomas Vanasek, David Stepek, Ferdinando D'Amico, Rachel West, Lennard P L Gilissen, Maria Wisniewska Jarosinka, Piotr Drobinski, Grzegorz Fronik, Mirosław Fic, Michał Walczak, Maciej Kowalski, Bartosz Korczowski, Michal Wiatr, Laurent Peyrin-Biroulet
Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis-The OPTIMISE Study. Journal of clinical medicine 13 (17) (2024)
Bénédicte Caron, Alexandre Habert, Olivier Bonsack, Houda Camara, Elodie Jeanbert, Tommaso Lorenzo Parigi, Patrick Netter, Silvio Danese, Laurent Peyrin Biroulet
Difficult-to-treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment. United European gastroenterology journal 12 (5) (2024)
Silvio Danese, Laurent Peyrin Biroulet
Are all the IL-23 blockers the same in inflammatory bowel disease? Nature reviews. Gastroenterology & hepatology (2024)
Ilaria Faggiani, Jacopo Fanizza, Ferdinando D'Amico, Mariangela Allocca, Alessandra Zilli, Tommaso Lorenzo Parigi, Alberto Barchi, Silvio Danese, Federica Furfaro
Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment. Biomedicines 12 (8) (2024)
Mariangela Allocca, Gaia Catalano, Edoardo V Savarino, Maria Chaparro, Asaf Levartovsky, George Michalopoulos, Nikos Viazis, Fotis S Fousekis, Andreas Psistakis, Daniele Noviello, Catarina Neto do Nascimento, Benedicte Caron, Vassiliki Kitsou, Giorgos Bamias, María José García, Eirini Zacharopoulou, Kalliopi Foteinogiannopoulou, Ferdinando D'Amico, Ioannis Koutroubakis, Pierre Ellul, Maria Tzouvala, Laurent Peyrin Biroulet, Joanna Torres, Flavio Caprioli, Konstantinos Karmiris, Angeliki Theodoropoulou, Konstantinos H Katsanos, Dimitrios K Christodoulou, Gerassimos J Mantzaris, Uri Kopylov, Francisco Javier García-Alonso, Silvio Danese, Fernando Magro, Fornari Carla, Gionata Fiorino
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study. United European gastroenterology journal 12 (5) (2024)
Sudheer Kumar Vuyyuru, Virginia Solitano, Siddharth Singh, Jurij Hanžel, John K Macdonald, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath
Scoring Indices for Perianal Fistulising Crohn's Disease: A Systematic Review. Journal of Crohn's & colitis 18 (6) (2024)
Mina Hassan-Zahraee, Zhan Ye, Li Xi, Elizabeth Dushin, Julie Lee, Jacek Romatowski, Jaroslaw Leszczyszyn, Silvio Danese, William J Sandborn, Christopher Banfield, Jeremy D Gale, Elena Peeva, Randy S Longman, Craig L Hyde, Kenneth E Hung
Baseline Serum and Stool Microbiome Biomarkers Predict Clinical Efficacy and Tissue Molecular Response After Ritlecitinib Induction Therapy in Ulcerative Colitis. Journal of Crohn's & colitis 18 (9) (2024)
Sailish Honap, Silvio Danese, Laurent Peyrin-Biroulet
Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized Trials. Inflammatory bowel diseases (2024)
Silvio Danese, Laurent Peyrin Biroulet
Are all the IL-23 blockers the same in inflammatory bowel disease? Nature reviews. Gastroenterology & hepatology 21 (3) (2024)
Jacopo Fanizza, Sarah Bencardino, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Tommaso Lorenzo Parigi, Gionata Fiorino, Laurent Peyrin-Biroulet, Silvio Danese, Ferdinando D'Amico
Inflammatory Bowel Disease and Colorectal Cancer. Cancers 16 (17) (2024)
Bruce E Sands, Silvio Danese, J Casey Chapman, Khushboo Gurjar, Stacy Grieve, Deepika Thakur, Jenny Griffith, Namita Joshi, Kristina Kligys, Axel Dignass
Mucosal and Transmural Healing and Long-term Outcomes in Crohn's Disease. Inflammatory bowel diseases (2024)
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, Julian Panés, Stefan Schreiber, Walter Reinisch, Brian G Feagan, Silvio Danese, Andres J Yarur, Geert R D'Haens, Martina Goetsch, Karolina Wosik, Michael Keating, Krisztina Lazin, Joseph Wu, Irene Modesto, Aoibhinn McDonnell, Lauren Bartolome, Séverine Vermeire
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme. Journal of Crohn's & colitis (2024)
Silvio Danese, Axel Dignass, Katsuyoshi Matsuoka, Marc Ferrante, Millie Long, Isabel Redondo, Richard Moses, Sebastian Maier, Theresa Hunter Gibble, Nathan Morris, Catherine Milch, Maria T Abreu
Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Program. Journal of Crohn's & colitis (2024)
Ferdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese
Benefits of Biosimilars in the Management of Patients with Inflammatory Bowel Disease: An International Survey. Journal of clinical medicine 13 (11) (2024)
Bénédicte Caron, Alexandre Habert, Olivier Bonsack, Houda Camara, Elodie Jeanbert, Tommaso Lorenzo Parigi, Patrick Netter, Silvio Danese, Laurent Peyrin Biroulet
Difficult-to-treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment. United European gastroenterology journal 12 (5) (2024)
Fernando Magro, Samuel Fernandes, Marta Patita, Bruno Arroja, Paula Lago, Isadora Rosa, Helena Tavares de Sousa, Paula Ministro, Irina Mocanu, Ana Vieira, Joana Castela, Joana Moleiro, Fernando Magro, Eugénia Cancela, Paula Sousa, Francisco Portela, Luís Correia, Paula Moreira, Sandra Dias, Joana Afonso, Silvio Danese, Laurent Peyrin-Biroulet, Katarina M Vucicevic, Mafalda Santiago
The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients. Journal of Crohn's & colitis 18 (7) (2024)
Sailish Honap, Nelly Agrinier, Silvio Danese, Laurent Peyrin Biroulet
Disease prevention trials in IBD: feasibility to future outlook. Nature reviews. Gastroenterology & hepatology (2024)
Ilaria Faggiani, Jacopo Fanizza, Ferdinando D'Amico, Mariangela Allocca, Alessandra Zilli, Tommaso Lorenzo Parigi, Alberto Barchi, Silvio Danese, Federica Furfaro
Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment. Biomedicines 12 (8) (2024)
Mariangela Allocca, Gaia Catalano, Edoardo V Savarino, Maria Chaparro, Asaf Levartovsky, George Michalopoulos, Nikos Viazis, Fotis S Fousekis, Andreas Psistakis, Daniele Noviello, Catarina Neto do Nascimento, Benedicte Caron, Vassiliki Kitsou, Giorgos Bamias, María José García, Eirini Zacharopoulou, Kalliopi Foteinogiannopoulou, Ferdinando D'Amico, Ioannis Koutroubakis, Pierre Ellul, Maria Tzouvala, Laurent Peyrin Biroulet, Joanna Torres, Flavio Caprioli, Konstantinos Karmiris, Angeliki Theodoropoulou, Konstantinos H Katsanos, Dimitrios K Christodoulou, Gerassimos J Mantzaris, Uri Kopylov, Francisco Javier García-Alonso, Silvio Danese, Fernando Magro, Fornari Carla, Gionata Fiorino
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study. United European gastroenterology journal 12 (5) (2024)
Fábio Vieira Teixeira, Laurent Peyrin Biroulet, Silvio Danese
ARE WE READY FOR MULTIPLE SWITCHES BETWEEN REFERENCE PRODUCTS AND BIOSIMILARS? Arquivos de gastroenterologia 61 (2024)
Francesca Lusetti, Ferdinando D'Amico, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Gionata Fiorino, Tommaso Lorenzo Parigi, Simona Radice, Laurent Peyrin-Biroulet, Silvio Danese
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease. Immunotherapy (2024)
Subrata Ghosh, Brian G Feagan, Elyssa Ott, Christopher Gasink, Bridget Godwin, Colleen Marano, Ye Miao, Tony Ma, Edward V Loftus, William J Sandborn, Silvio Danese, Maria T Abreu, Bruce E Sands
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis. Journal of Crohn's & colitis (2024)
Subrata Ghosh, Brian G Feagan, Elyssa Ott, Christopher Gasink, Bridget Godwin, Colleen Marano, Ye Miao, Tony Ma, Edward V Loftus, William J Sandborn, Silvio Danese, Maria T Abreu, Bruce E Sands
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis. Journal of Crohn's & colitis 18 (7) (2024)
Sara Massironi, Alessandro Pigoni, Elena Anna Maria Vegni, Laurie Keefer, Marla C Dubinsky, Paolo Brambilla, Giuseppe Delvecchio, Silvio Danese
The Burden of Psychiatric Manifestations in Inflammatory Bowel Diseases: A Systematic Review With Meta-analysis. Inflammatory bowel diseases (2024)
Maria Jose Temido, Sailish Honap, Silvio Danese, Vipul Jairath, Fernando Magro, Francisco Portela, Laurent Peyrin-Biroulet
Nested Randomized Controlled Trials in Large Databases: An Opportunity for Inflammatory Bowel Disease? Journal of Crohn's & colitis (2024)
Clelia Cicerone, Ferdinando D'Amico, Mariangela Allocca, Alessandra Zilli, Tommaso Lorenzo Parigi, Silvio Danese, Federica Furfaro
A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Brian G Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Séverine Vermeire, Silvio Danese, Edward V Loftus, Ian L P Beales, Stefan Schreiber, Hyo Jong Kim, Margaux Faes, Angela de Haas, Tomasz Masior, Christine Rudolph, Laurent Peyrin Biroulet
Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study. Alimentary pharmacology & therapeutics 60 (5) (2024)
Ferdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese
Benefits of Biosimilars in the Management of Patients with Inflammatory Bowel Disease: An International Survey. Journal of clinical medicine 13 (11) (2024)
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, Julian Panes, Stefan Schreiber, Walter Reinisch, Brian G Feagan, Silvio Danese, Andres J Yarur, Geert R A M D'Haens, Martina Goetsch, Karolina Wosik, Michael Keating, Krisztina Lazin, Joseph Wu, Irene Modesto, Aoibhinn McDonnell, Lauren Bartolome, Severine Vermeire
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme. Journal of Crohn's & colitis 18 (8) (2024)
Clelia Cicerone, Ferdinando D'Amico, Mariangela Allocca, Alessandra Zilli, Tommaso Lorenzo Parigi, Silvio Danese, Federica Furfaro
A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Ilaria Faggiani, Ferdinando D'Amico, Federica Furfaro, Alessandra Zilli, Tommaso Lorenzo Parigi, Clelia Cicerone, Gionata Fiorino, Laurent Peyrin-Biroulet, Silvio Danese, Mariangela Allocca
Small Bowel Cancer in Crohn's Disease. Cancers 16 (16) (2024)
Ilaria Faggiani, Ferdinando D'Amico, Federica Furfaro, Alessandra Zilli, Tommaso Lorenzo Parigi, Clelia Cicerone, Gionata Fiorino, Laurent Peyrin-Biroulet, Silvio Danese, Mariangela Allocca
Small Bowel Cancer in Crohn's Disease. Cancers 16 (16) (2024)
Mariangela Allocca, Gaia Catalano, Edoardo V Savarino, Maria Chaparro, Asaf Levartovsky, George Michalopoulos, Nikos Viazis, Fotis S Fousekis, Andreas Psistakis, Daniele Noviello, Catarina Neto do Nascimento, Benedicte Caron, Vassiliki Kitsou, Giorgos Bamias, María José García, Eirini Zacharopoulou, Kalliopi Foteinogiannopoulou, Ferdinando D'Amico, Ioannis Koutroubakis, Pierre Ellul, Maria Tzouvala, Laurent Peyrin Biroulet, Joanna Torres, Flavio Caprioli, Konstantinos Karmiris, Angeliki Theodoropoulou, Konstantinos H Katsanos, Dimitrios K Christodoulou, Gerassimos J Mantzaris, Uri Kopylov, Francisco Javier García-Alonso, Silvio Danese, Fernando Magro, Fornari Carla, Gionata Fiorino
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study. United European gastroenterology journal 12 (5) (2024)
Jurij Hanžel, Christopher Ma, Laurent Peyrin-Biroulet, Silvio Danese, Bruce E Sands, Vipul Jairath
Differences Between the 2016 and 2022 Food and Drug Administration Guidance-Implications for Design and Interpretation of Clinical Trials in Ulcerative Colitis. Crohn's & colitis 360 6 (2) (2024)
Séverine Vermeire, Bruce E Sands, Laurent Peyrin-Biroulet, Geert R D'Haens, Julian Panés, Andres J Yarur, Douglas C Wolf, Timothy Ritter, Stefan Schreiber, John C Woolcott, Irene Modesto, Michael Keating, Kevin Shan, Joseph Wu, Michael V Chiorean, Filip Baert, Marla C Dubinsky, Martina Goetsch, Silvio Danese, Brian G Feagan
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials. Journal of Crohn's & colitis (2024)
Clelia Cicerone, Ferdinando D'Amico, Mariangela Allocca, Alessandra Zilli, Tommaso Lorenzo Parigi, Silvio Danese, Federica Furfaro
A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Silvio Danese, Jacinda Tran, Geert D'Haens, David T Rubin, Nobuo Aoyama, Wen Zhou, Dapo Ilo, Xuan Yao, Yuri Sanchez Gonzalez, Remo Panaccione
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data. Inflammatory bowel diseases (2023)
Sarah Bencardino, Ferdinando D'Amico, Ilaria Faggiani, Francesca Bernardi, Mariangela Allocca, Federica Furfaro, Tommaso Lorenzo Parigi, Alessandra Zilli, Gionata Fiorino, Laurent Peyrin-Biroulet, Silvio Danese
Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis. Journal of clinical medicine 12 (15) (2023)
Jacopo Fanizza, Ferdinando D'Amico, Gaetano Lauri, Samuel J Martinez-Dominguez, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Gionata Fiorino, Tommaso Lorenzo Parigi, Simona Radice, Laurent Peyrin-Biroulet, Silvio Danese
The role of filgotinib in ulcerative colitis and Crohn's disease. Immunotherapy (2023)
Sara Massironi, Giacomo Mulinacci, Camilla Gallo, Chiara Viganò, Maria Fichera, Andrea Villatore, Giovanni Peretto, Silvio Danese
The oft-overlooked cardiovascular complications of inflammatory bowel disease. Expert review of clinical immunology (2023)
Gaetano Lauri, Ferdinando D'Amico, Mariangela Allocca, Diego Palumbo, Emanuel Della-Torre, Francesco De Cobelli, Claudio Doglioni, Paolo Giorgio Arcidiacono, Gabriele Capurso, Silvio Danese
Ustekinumab as induction and maintenance therapy in patients with inflammatory bowel disease and type II autoimmune pancreatitis: report of two cases. Journal of Crohn's & colitis (2023)
Loris Riccardo Lopetuso, Sara Deleu, Lihi Godny, Valentina Petito, Pierluigi Puca, Federica Facciotti, Harry Sokol, Gianluca G Ianiro, Luca Masucci, Maria Abreu, Iris Dotan, Samuel Paul Costello, Ailsa Hart, Tariq H Iqbal, Sudarshan Paramsothy, Maurizio Sanguinetti, Silvio Danese, Herbert Tilg, Fabio Cominelli, Theresa T Pizarro, Alessandro Armuzzi, Giovanni Cammarota, Antonio Gasbarrini, Severine Vermeire, Franco Scaldaferri
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease. Gut (2023)
Ferdinando D'Amico, Fernando Magro, Britta Siegmund, Taku Kobayashi, Paulo Gustavo Kotze, Virginia Solitano, Benedicte Caron, Sameer Al Awadhi, Ailsa Hart, Vipul Jairath, Axel Dignass, Laurent Peyrin-Biroulet, Silvio Danese
Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus. Inflammatory bowel diseases (2023)
Mina Hassan-Zahraee, Zhan Ye, Li Xi, Elizabeth Dushin, Julie Lee, Jacek Romatowski, Jaroslaw Leszczyszyn, Silvio Danese, William J Sandborn, Christopher Banfield, Jeremy D Gale, Elena Peeva, Randy S Longman, Craig L Hyde, Kenneth E Hung
Baseline serum and stool microbiome biomarkers predict clinical efficacy and tissue molecular response after ritlecitinib induction therapy in ulcerative colitis. Journal of Crohn's & colitis (2023)
Bénédicte Caron, Vipul Jairath, Valérie Laurent, Jaap Stoker, Andrea Laghi, Geert R D'Haens, Silvio Danese, Laurent Peyrin-Biroulet
Defining magnetic resonance imaging treatment response and remission in Crohn's disease: a systematic review. Journal of Crohn's & colitis (2023)
Stefan Schreiber, Gerhard Rogler, Mamoru Watanabe, Severine Vermeire, Christian Maaser, Silvio Danese, Margaux Faes, Paul Van Hoek, Jeremy Hsieh, Ulrik Moerch, Yan Zhou, Angela de Haas, Christine Rudolph, Alessandra Oortwijn, Edward V Loftus
Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE. Alimentary pharmacology & therapeutics (2023)
Sara Massironi, Giacomo Mulinacci, Camilla Gallo, Chiara Viganò, Maria Fichera, Andrea Villatore, Giovanni Peretto, Silvio Danese
The oft-overlooked cardiovascular complications of inflammatory bowel disease. Expert review of clinical immunology (2023)
Francesco Vito Mandarino, Emanuele Sinagra, Dario Raimondo, Silvio Danese
The Role of Microbiota in Upper and Lower Gastrointestinal Functional Disorders. Microorganisms 11 (4) (2023)
Antonio Tursi, Daniele Piovani, Giovanni Brandimarte, Francesco Di Mario, Walter Elisei, Marcello Picchio, Leonardo Allegretta, Maria Laura Annunziata, Mauro Bafutto, Gabrio Bassotti, Maria Antonia Bianco, Raffaele Colucci, Rita Conigliaro, Dan L Dumitrascu, Ricardo Escalante, Luciano Ferrini, Giacomo Forti, Marilisa Franceschi, Maria Giovanna Graziani, Frank Lammert, Giovanni Latella, Giovanni Maconi, Debora Compare, Gerardo Nardone, Lucia Camara De Castro Oliveira, Enio Chaves Oliveira, Alfredo Papa, Savvas Papagrigoriadis, Anna Pietrzak, Stefano Pontone, Tomas Poskus, Giuseppe Pranzo, Matthias Christian Reichert, Stefano Rodinò, Jaroslaw Reguła, Giuseppe Scaccianoce, Franco Scaldaferri, Roberto Vassallo, Costantino Zampaletta, Angelo Zullo, Erasmo Spaziani, Stefanos Bonovas, Silvio Danese, null null
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis. United European gastroenterology journal (2023)
Pablo Andres Olivera, Juan S Lasa, Giovanni Peretto, Stephane Zuily, Silvio Danese, Laurent Peyrin Biroulet
Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs. Alimentary pharmacology & therapeutics (2023)
Stefan Schreiber, David T Rubin, Siew C Ng, Laurent Peyrin-Biroulet, Silvio Danese, Irene Modesto, Xiang Guo, Chinyu Su, Kenneth K Kwok, Hyejin Jo, Yan Chen, Arne Yndestad, Walter Reinisch, Marla C Dubinsky
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme. Journal of Crohn's & colitis (2023)
Sudheer Kumar Vuyyuru, Virginia Solitano, Siddharth Singh, Jurij Hanzel, John K Macdonald, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath
Scoring indices for perianal fistulizing Crohn's disease: A systematic review. Journal of Crohn's & colitis (2023)
Kenji Watanabe, Laurent Peyrin-Biroulet, Silvio Danese, Yasushi Fujitani, Margaux Faes, Alessandra Oortwijn, James O Lindsay, Gerhard Rogler, Toshifumi Hibi
Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post hoc Analysis of the Phase 2b/3 SELECTION Study. Journal of Crohn's & colitis (2023)
Gaetano Lauri, Ferdinando D'Amico, Mariangela Allocca, Diego Palumbo, Emanuel Della-Torre, Francesco De Cobelli, Claudio Doglioni, Paolo Giorgio Arcidiacono, Gabriele Capurso, Silvio Danese
Ustekinumab as induction and maintenance therapy in patients with inflammatory bowel disease and type II autoimmune pancreatitis: report of two cases. Journal of Crohn's & colitis (2023)
Pauline Wils, Silvio Danese, Laurent Peyrin-Biroulet
Promising phase II biologics for future Crohn's disease therapy. Expert opinion on investigational drugs (2023)
Ferdinando D'Amico, Sara Massironi, Mariangela Allocca, Silvio Danese
Advancing transmural remission as a treatment target in Crohn's disease: The future of tight-control strategy? United European gastroenterology journal (2023)
Sara Massironi, Pierpaolo Sileri, Silvio Danese
Get Fit: Muscle Health for Crohn's Disease Surgical Outcome Optimization. Inflammatory bowel diseases (2023)
Francesco Vito Mandarino, Emanuele Sinagra, Dario Raimondo, Silvio Danese
The Role of Microbiota in Upper and Lower Gastrointestinal Functional Disorders. Microorganisms 11 (4) (2023)
Bénédicte Caron, Vipul Jairath, Ferdinando D'Amico, Sameer Al Awadhi, Axel U Dignass, Ailsa L Hart, Taku Kobayashi, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Kristine Paridaens, Silvio Danese, Laurent Peyrin-Biroulet
International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Silvio Danese, Remo Panaccione, Maria T Abreu, David T Rubin, Subrata Ghosh, Axel Dignass, Anita Afzali, Douglas C Wolf, Michael V Chiorean, Severine Vermeire, Anjali Jain, Lorna Charles, Garrett Lawlor, Mark T Osterman, Hsiuanlin Wu, James B Canavan, Ann Katrin Petersen, Jean Frederic Colombel, Miguel Regueiro
Efficacy and safety of approximately 3 years of continuous ozanimod in moderately to severely active ulcerative colitis: interim analysis of the True North open-label extension. Journal of Crohn's & colitis (2023)
Ferdinando D'Amico, Fernando Magro, Benedicte Caron, Axel U Dignass, Vipul Jairath, Ailsa Hart, Paulo Gustavo Kotze, Kristine Paridaens, Sameer Al Awadhi, Taku Kobayashi, Britta Siegmund, Laurent Peyrin-Biroulet, Silvio Danese
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis. Journal of clinical medicine 12 (3) (2023)
Bénédicte Caron, Vipul Jairath, Ferdinando D'Amico, Sameer Al Awadhi, Axel U Dignass, Ailsa L Hart, Taku Kobayashi, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Kristine Paridaens, Silvio Danese, Laurent Peyrin-Biroulet
International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Séverine Vermeire, Virginia Solitano, Laurent Peyrin-Biroulet, Herbert Tilg, Silvio Danese, Hartmut Ehrlich, Didier Scherrer, Paul Gineste, Laurence d'Agay, Bruce E Sands
Obefazimod: A First-in-class Drug for the Treatment of Ulcerative Colitis. Journal of Crohn's & colitis (2023)
Bénédicte Caron, Vipul Jairath, Ferdinando D'Amico, Sameer Al Awadhi, Axel U Dignass, Ailsa L Hart, Taku Kobayashi, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Kristine Paridaens, Silvio Danese, Laurent Peyrin-Biroulet
International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Sailish Honap, Anne Buisson, Silvio Danese, Beaugerie Laurent, Laurent Peyrin-Biroulet
Patient and Public Involvement in Research: Lessons for Inflammatory Bowel Disease. Journal of Crohn's & colitis (2023)
Laura Neurath, Ferdinando D'Amico, Silvio Danese
Emerging drugs for the treatment of moderately to severely active ulcerative colitis: Review of phase II and III clinical trials. Expert opinion on emerging drugs (2023)
Gaetano Lauri, Ferdinando D'Amico, Mariangela Allocca, Diego Palumbo, Emanuel Della-Torre, Francesco De Cobelli, Claudio Doglioni, Paolo Giorgio Arcidiacono, Gabriele Capurso, Silvio Danese
Ustekinumab as induction and maintenance therapy in patients with inflammatory bowel disease and type II autoimmune pancreatitis: report of two cases. Journal of Crohn's & colitis (2023)
Stefan Schreiber, Silvio Danese, Axel Dignass, Eugeni Domènech, Massimo C Fantini, Marc Ferrante, Jonas Halfvarson, Ailsa Hart, Fernando Magro, Charlie W Lees, Salvo Leone, Marieke J Pierik, Michele Peters, Polly Field, Helen Fishpool, Laurent Peyrin-Biroulet
Defining Comprehensive Disease Control for use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations. Journal of Crohn's & colitis (2023)
Ferdinando D'Amico, Sophie Vieujean, Benedicte Caron, Laurent Peyrin-Biroulet, Silvio Danese
Risk-Benefit of IBD Drugs: A Physicians and Patients Survey. Journal of clinical medicine 12 (9) (2023)
Mina Hassan-Zahraee, Zhan Ye, Li Xi, Elizabeth Dushin, Julie Lee, Jacek Romatowski, Jaroslaw Leszczyszyn, Silvio Danese, William J Sandborn, Christopher Banfield, Jeremy D Gale, Elena Peeva, Randy S Longman, Craig L Hyde, Kenneth E Hung
Baseline serum and stool microbiome biomarkers predict clinical efficacy and tissue molecular response after ritlecitinib induction therapy in ulcerative colitis. Journal of Crohn's & colitis (2023)
Francesco Vito Mandarino, Emanuele Sinagra, Dario Raimondo, Silvio Danese
The Role of Microbiota in Upper and Lower Gastrointestinal Functional Disorders. Microorganisms 11 (4) (2023)
Sophie Vieujean, Edouard Louis, Silvio Danese, Laurent Peyrin-Biroulet
A critical review of ustekinumab for the treatment of active ulcerative colitis in adults. Expert review of gastroenterology & hepatology (2023)
Ferdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese
Disease Clearance is not Synonymous with Cure. Inflammatory bowel diseases (2023)
Nicole Piazza O Sed, Daniele Noviello, Elisabetta Filippi, Francesco Conforti, Federica Furfaro, Mirella Fraquelli, Andrea Costantino, Silvio Danese, Maurizio Vecchi, Gionata Fiorino, Mariangela Allocca, Flavio Andrea Caprioli
Superior predictive value of transmural over endoscopic severity for colectomy risk in ulcerative colitis: a multicenter prospective cohort study. Journal of Crohn's & colitis (2023)
Laura Neurath, Ferdinando D'Amico, Silvio Danese
Emerging drugs for the treatment of moderately to severely active ulcerative colitis: review of phase II and III clinical trials. Expert opinion on emerging drugs (2023)
Achuthan Aruljothy, Siddharth Singh, Neeraj Narula, Gordon William Moran, Sudheer K Vuyyuru, Malcolm Hogan, Alexa Zayadi, John K MacDonald, Benedicte Caron, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath
Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis. Alimentary pharmacology & therapeutics (2023)
Stefan Schreiber, Brian G Feagan, Laurent Peyrin-Biroulet, Séverine Vermeire, Margaux Faes, Kristina Harris, Alessandra Oortwijn, Patrick Daniele, Haridarshan Patel, Silvio Danese
Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from SELECTION. Journal of Crohn's & colitis (2023)
Sophie Vieujean, James O Lindsay, Ferdinando D'Amico, Vineet Ahuja, Mark S Silverberg, Ajit Sood, Jesus K Yamamoto-Furusho, Masakazu Nagahori, Mamoru Watanabe, Ioannis E Koutroubakis, Kalliopi Foteinogiannopoulou, Irit Avni Biron, Alissa Walsh, An Outtier, Rie Louise Møller Nordestgaard, Maria T Abreu, Marla Dubinsky, Corey Allan Siegel, Edouard Louis, Iris Dotan, Walter Reinisch, Silvio Danese, David T Rubin, Laurent Peyrin-Biroulet
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases (IBD): Real World Results from the International Organization for the study of IBD. Journal of Crohn's & colitis (2023)
Laurent Peyrin Biroulet, Severine Vermeire, Geert D'Haens, Julian Panes, Axel U Dignass, Fernando Magro, Maciej Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Ivana Bravatà, Frederic Lavie, Marco Daperno, Milan Lukáš, Alessandro Armuzzi, Mark Löwenberg, Daniel R Gaya, Silvio Danese
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUST. Alimentary pharmacology & therapeutics (2023)
Silvio Danese, Virginia Solitano, Vipul Jairath, Laurent Peyrin Biroulet
Risk minimization of JAK inhibitors in ulcerative colitis following regulatory guidance. Nature reviews. Gastroenterology & hepatology 20 (3) (2023)
Remo Panaccione, Eric B Collins, Gil Y Melmed, Severine Vermeire, Silvio Danese, Peter D R Higgins, Christina S Kwon, Wen Zhou, Dapo Ilo, Dolly Sharma, Yuri Sanchez Gonzalez, Si-Tien Wang
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis. Crohn's & colitis 360 5 (2) (2023)
Séverine Vermeire, Silvio Danese, William J Sandborn, Stefan Schreiber, Stephen Hanauer, Geert D'Haens, Peter Nagy, Manoj Thakur, Caleb Bliss, Fabio Cataldi, Martina Goetsch, Kenneth J Gorelick, Walter Reinisch
Efficacy and Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease. Journal of Crohn's & colitis (2023)
Francesco Vito Mandarino, Emanuele Sinagra, Dario Raimondo, Silvio Danese
The Role of Microbiota in Upper and Lower Gastrointestinal Functional Disorders. Microorganisms 11 (4) (2023)

Silvio Danese.css-eqlu8i{font-size:small;padding-left:4px;} (S Danese)

Publication Activity (10 Years)

Top Topics

Top Venues

Silvio Danese (S Danese)